BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Geng J, Xia X, Teng L, Wang L, Chen L, Guo X, Belingon B, Li J, Feng X, Li X, Shang W, Wan Y, Wang H. Emerging landscape of cell-penetrating peptide-mediated nucleic acid delivery and their utility in imaging, gene-editing, and RNA-sequencing. J Control Release 2021;341:166-83. [PMID: 34822907 DOI: 10.1016/j.jconrel.2021.11.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li S, Zhang MY, Yuan J, Zhang YX. Nano-vaccines for gene delivery against HIV-1 infection. Expert Rev Vaccines 2023. [PMID: 36945780 DOI: 10.1080/14760584.2023.2193266] [Reference Citation Analysis]
2 Li X, Wang J, Geng J, Xiao L, Wang H. Emerging Landscape of SARS-CoV-2 Variants and Detection Technologies. Mol Diagn Ther 2023;27:159-77. [PMID: 36577887 DOI: 10.1007/s40291-022-00631-0] [Reference Citation Analysis]
3 Geng J, Wang J, Wang H. Emerging Landscape of Cell-Penetrating Peptide-Mediated Organelle Restoration and Replacement. ACS Pharmacol Transl Sci 2023;6:229-44. [PMID: 36798470 DOI: 10.1021/acsptsci.2c00229] [Reference Citation Analysis]
4 Ye X, Li J, Liu Z, Sun X, Wei D, Song L, Wu C. Peptide mediated therapy in fibrosis: Mechanisms, advances and prospects. Biomed Pharmacother 2023;157:113978. [PMID: 36423541 DOI: 10.1016/j.biopha.2022.113978] [Reference Citation Analysis]
5 Guo S, Zhang D, Wang H, An Q, Yu G, Han J, Jiang C, Huang J. Editorial: Computational and systematic analysis of multi-omics data for drug discovery and development. Front Med (Lausanne) 2023;10:1146896. [PMID: 36895719 DOI: 10.3389/fmed.2023.1146896] [Reference Citation Analysis]
6 Wang F, Zhan Y, Li M, Wang L, Zheng A, Liu C, Wang H, Wang T. Cell-Permeable PROTAC Degraders against KEAP1 Efficiently Suppress Hepatic Stellate Cell Activation through the Antioxidant and Anti-Inflammatory Pathway. ACS Pharmacol Transl Sci 2023;6:76-87. [PMID: 36654751 DOI: 10.1021/acsptsci.2c00165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nakamura M, Fujiwara K, Doi N. Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide. J Nanobiotechnology 2022;20:458. [PMID: 36303212 DOI: 10.1186/s12951-022-01667-4] [Reference Citation Analysis]
8 Su L, Sun Z, Qi F, Su H, Qian L, Li J, Zuo L, Huang J, Yu Z, Li J, Chen Z, Zhang S. GRP75-driven, cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+ nanoparticles underlies distinct gene therapy effect in ovarian cancer. J Nanobiotechnology 2022;20:340. [PMID: 35858873 DOI: 10.1186/s12951-022-01530-6] [Reference Citation Analysis]
9 Yuan X, Luo SZ, Chen L. Novel branched amphiphilic peptides for nucleic acids delivery. Int J Pharm 2022;624:121983. [PMID: 35803534 DOI: 10.1016/j.ijpharm.2022.121983] [Reference Citation Analysis]
10 Asakiya C, Zhu L, Yuhan J, Zhu L, Huang K, Xu W. Current progress of miRNA-derivative nucleotide drugs: Modifications, delivery systems, applications. Expert Opin Drug Deliv 2022. [PMID: 35387533 DOI: 10.1080/17425247.2022.2063835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang L, Geng J, Chen L, Guo X, Wang T, Fang Y, Belingon B, Wu J, Li M, Zhan Y, Shang W, Wan Y, Feng X, Li X, Wang H. Improved transfer efficiency of supercharged 36 + GFP protein mediate nucleic acid delivery. Drug Deliv 2022;29:386-98. [PMID: 35075948 DOI: 10.1080/10717544.2022.2030430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang D, Tian Y, Zhang Y, Sun X, Wu Y, Liu R, Zeng F, Du J, Hu K. An assembly-inducing PDC enabling the efficient nuclear delivery of nucleic acid for cancer stem-like cell suppression. Nanoscale 2022;14:15384-15392. [DOI: 10.1039/d2nr02118h] [Reference Citation Analysis]